Clinical trial
A Type 2 Diabetes Study of the Longer-Term Glycemic Effect of AVANDAMET vs…
NCT00386100 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00386100 |
|---|---|
| Title | A Type 2 Diabetes Study of the Longer-Term Glycemic Effect of AVANDAMET vs. Metformin |
| Official title | A Randomized, Parallel Group, Double-blind, Multi-center Study Comparing the Efficacy and Safety of AVANDAMET and Metformin After 80 Weeks of Treatment. |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | Avandamet 6 mg/1500 mg (ttd), Avandamet 4 mg/1000 mg (ttd), Avandamet 2 mg/500 mg (ttd), Avandamet 8 mg/ 2000 mg (ttd), Metformin 500 mg (ttd), Metformin 1000 mg (ttd), Metformin 1500 mg (ttd), Metformin 2000 mg (ttd) |
| Enrollment | 688 |
| Start date | Oct 1, 2006 |
| Primary completion | Sep 1, 2009 |
| Completion | Sep 1, 2009 |
| First posted | Oct 11, 2006 |
| Last update posted | Nov 23, 2016 |
| Countries | Argentina, Brazil, Canada, Mexico, Pakistan, Philippines, South Korea, Taiwan, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: